Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2007
10/31/2007CN101062101A Material formula of olive fruit buccal tablet and the preparing method thereof
10/31/2007CN101062097A Compound for improving and treating fatty liver disease
10/31/2007CN101062094A Total salvianolic acids long-cycle liposomes and the preparing method thereof
10/31/2007CN101062084A Anti-hepatitis medical combination
10/31/2007CN101062083A Processing method for reducing the poison of triptolide and the corresponding preparation
10/31/2007CN101062048A Application of ginsenoside Rg1 in the preparing of medicine
10/31/2007CN101062047A Combination including isoglycyrrhizinate and oxymatrine and the purpose thereof
10/31/2007CN101062046A Medical function of saponin component
10/31/2007CN101062031A Method of controlling the quality of silymarin oral aolid preparation
10/31/2007CN101062030A Method of preparing silybin frozen powder injection
10/31/2007CN101062024A Pronin medicinal composition and its preparing method
10/31/2007CN101062021A Diarrhea treating medical composition
10/31/2007CN101062015A Urease epitope fusion peptide liposome bacterin for preventing the helicobacter pylori infecting
10/31/2007CN101061881A Xylitol nourishing beverage and the method of processing the same
10/31/2007CN101061864A Health-care beverage for improving the gastrointestinal function
10/31/2007CN101061857A Food seasoning and method of producing the same
10/31/2007CN101061825A Cachou for clearing head and preventing vomiting
10/31/2007CN101061823A Supine gynura root and the producing method thereof
10/31/2007CN100345853C Pyrazolopyrimidine compound and method for producing the same
10/31/2007CN100345849C Enantiomer (-) of tenatoprazole and the therapeutic use thereof
10/31/2007CN100345847C Novel biarylcarboxamides
10/31/2007CN100345843C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
10/31/2007CN100345840C Stable hydrate of a muscarinic receptor antagonist
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007CN100345590C Lozenge containing liver cell growth promoting agent and interferon
10/31/2007CN100345586C Chinese traditional medicine and western medicine composition for treating hepatitis
10/31/2007CN100345578C Medicine for auxiliary treating hepatitis
10/31/2007CN100345575C Chinese-medicinal preparation for treating gastropathy and its making method
10/31/2007CN100345570C Health care product for treating intestine duct disease, preparation and use method thereof
10/31/2007CN100345563C Chinese medicine for treating animal's dysenteric diarrhoea and its prepn process
10/31/2007CN100345561C Chinese medicinal preparation for treating gallstone and its preparation method
10/31/2007CN100345552C Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/31/2007CN100345551C Preparation of elaioplast and lipid compound preparation of nucleoside-phosphate compound
10/31/2007CN100345542C Tinizadole dental plaster for treating buccal inflammation
10/31/2007CN100345539C Composition containing dihydro myricitrin and myricitrin
10/31/2007CN100345534C Yinzhi huang capsule, its preparation method and use
10/31/2007CN100345533C Asiabell polysaccharide tablet of asiabell effective ingredient
10/30/2007US7288651 Such as (R)-4-bromo-N-[1-(2,4-dichlorophenyl)-ethyl]-2-(quinoxaline-5-quinoxaline-sulfonylamino)-benzamide via sulfonylation; cholecystokinin receptor modulators
10/30/2007US7288568 Alzheimer's disease; Parkinson's disease; inflammatory bowel disease; antiarthritic agents
10/30/2007US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders
10/30/2007US7288550 Administering 2-butyl-1-[5-(methylsulfonyl)pentyl]-1H-imidazo[4,5-c]quinolin-4-amine or salts to induce biosynthesis of cytokines such as IFN- alpha and/or TNF- alpha; treating viral diseases
10/30/2007US7288544 Calcium channel antagonistic activity; especially useful as analgesics
10/30/2007US7288519 Exocyclic peptide having amino acid sequence of a Fas surface domain; antagonists of the Fas receptor (Fas)-Fas ligand complex
10/30/2007US7288280 Complete feed for fish larvae and method for preparing same
10/30/2007US7288252 Administering antigen , or antagonist antibody; binding; antiproliferative agents; controlling cell differentiation
10/30/2007US7288225 Psyllium plant extracts; constipation therapy, gastrointestinal disorders
10/30/2007CA2451433C Oligopeptide transporter 1 inhibitor
10/30/2007CA2330424C Improved method for eradication of helicobacter pylori
10/30/2007CA2227497C Enteral dietary compositions comprising streptococcus thermophilus and bifidobacterium longum
10/30/2007CA2206995C Use of alkanoyl l-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases
10/30/2007CA2186757C Use of biopolymers for digestive tract injuries treatment
10/25/2007WO2007120768A1 Oral patch with salt of glycyrrhetinic acid water soluble at human mouth temperatures
10/25/2007WO2007120445A1 SOLUBLE SALTS OF THIENO [2,3-d] PYRIMIDINE DERIVATIVES
10/25/2007WO2007120101A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007WO2007119973A1 Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
10/25/2007WO2007119887A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ
10/25/2007WO2007119796A1 Mutant polypeptide having effector function
10/25/2007WO2007119684A1 Spraying agent
10/25/2007WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof
10/25/2007WO2007119600A1 Carbazole compound
10/25/2007WO2007119502A1 Bowel movement remedy
10/25/2007WO2007118967A1 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine
10/25/2007WO2007118259A1 Use of dried beer brewer's grains
10/25/2007WO2007080484A3 Flavonoids isolated from oroxylum indicum for treatment of gastrointestinal toxicity, associated symptoms and ulcers
10/25/2007WO2006103342A9 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
10/25/2007WO2003011210A3 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249720 Thiourea Derivative-Containing Pharmaceutical Composition Having Improved Solubility and Bioavailability
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249703 (Hydroxyphenyl)-1H-Indole-3-Carbaldehyde Oxime Derivatives As Estrogenic Agents
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007US20070249684 Solid Forms of the Magnesium Salt of S-Omeprazole and Processes for Their Preparation
10/25/2007US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
10/25/2007US20070249676 Cyanoguanidine prodrugs
10/25/2007US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/25/2007US20070249650 isolating and purifying quaternary ammonium alkaloid species from medicinal plant of Yan Huang Lian (Corydalis saxicola Bounting) through solvent extraction, crystallization and recrystallization; for treating viral hepatitis, hepatic injury, influenza, AIDS, tumors or arrhythmia
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249598 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma
10/25/2007US20070249551 Compositions and methods for non-parenteral delivery of oligonucleotides
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070248663 Utilization of Dialkylfumerates
10/25/2007US20070248662 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
10/25/2007US20070248649 Of soluble and insoluble carbohydrates for dietetics and pharmaceuticals to promote the flora of the large intestine, lactic acid bacteria, and in infant formulas; probiotics
10/25/2007US20070248617 Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
10/25/2007US20070248608 Monoclonal Antibodies to Progastrin
10/25/2007US20070248582 Lactic Bacteria and Their Use in the Prevention of Diarrhea
10/25/2007US20070248572 Method for treating diseases with omega interferon
10/25/2007DE102006017672A1 Zusammensetzung zur Verwendung als Laxativum A composition for use as a laxative
10/25/2007CA2649735A1 Activating agent for peroxisome proliferator activated receptor .delta.
10/25/2007CA2649700A1 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
10/25/2007CA2649287A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007CA2649286A1 2-hydroxybenzoic acid derivatives for treating or preventing degenerative and inflammatory diseases
10/25/2007CA2647501A1 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847541A1 Fused pyrimidine derivative and uses thereof
10/24/2007EP1847533A1 Six-membered heterocyclic compound and the use thereof
10/24/2007EP1847530A1 Diamine derivative
10/24/2007EP1845997A2 Apoptosis-inducing antineoplastic silver (i) coordination complexes
10/24/2007EP1845989A1 Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 1258